These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 3332004)
1. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004 [TBL] [Abstract][Full Text] [Related]
2. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327 [TBL] [Abstract][Full Text] [Related]
4. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030 [TBL] [Abstract][Full Text] [Related]
5. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
6. Amplification of the N-myc oncogene in an adenocarcinoma of the lung. Saksela K; Bergh J; Nilsson K J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069 [TBL] [Abstract][Full Text] [Related]
7. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers. Taya Y Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029 [TBL] [Abstract][Full Text] [Related]
9. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related]
10. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
11. [Recent progress in the biology of small cell bronchial carcinoma]. Thomas F; Arriagada R; Le Chevalier T; Poupon MF Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F; Poupon MF; Le Chevalier T Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823 [TBL] [Abstract][Full Text] [Related]
14. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
15. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related]
16. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Shiraishi M; Noguchi M; Shimosato Y; Sekiya T Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414 [TBL] [Abstract][Full Text] [Related]
17. myc family gene abnormality in lung cancers and its relation to xenotransplantability. Gemma A; Nakajima T; Shiraishi M; Noguchi M; Gotoh M; Sekiya T; Niitani H; Shimosato Y Cancer Res; 1988 Nov; 48(21):6025-8. PubMed ID: 3167852 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of oncogene product expression in human lung cancer]. Dosaka-Akita H; Harada M; Miyamoto H; Kawakami Y Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1441-7. PubMed ID: 1331597 [TBL] [Abstract][Full Text] [Related]
19. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933 [TBL] [Abstract][Full Text] [Related]
20. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Kiefer PE; Bepler G; Kubasch M; Havemann K Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]